Pilot immunisation programme sees drop in babies in hospital with RSV
Hiqa deputy chief executive and director of health technology assessment, Dr MáirĂn Ryan, said the two-year pilot immunisation programme has been 'very effective' in protecting babies.
The number of babies in hospital with respiratory syncytial virus (RSV) is expected to be even lower this year than last year as a “very effective” pilot immunisation programme continues, health watchdog Hiqa has said.
The regulator is now calling on parents, healthcare workers, and anyone interested in children’s health to take part in a public consultation around permanent funding for it.



